查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1761142

全球茲卡病毒檢測市場

Zika Virus Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球茲卡病毒檢測市場規模將達到 3.145 億美元

全球茲卡病毒檢測市場規模預計在2024年為2.245億美元，到2030年將達到3.145億美元，在2024-2030年的分析期間內，複合年成長率為5.8%。分子檢測是本報告分析的細分市場之一，預計其複合年成長率為6.4%，到分析期結束時規模將達到1.924億美元。血清學檢測細分市場在分析期間的複合年成長率預計為4.9%。

美國市場規模估計為 5,870 萬美元，中國市場預計複合年成長率為 9.9%

美國茲卡病毒檢測市場規模預計2024年達到5,870萬美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到7,550萬美元，2024年至2030年的複合年成長率為9.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為2.2%和5.9%。在歐洲，預計德國的複合年成長率為2.8%。

全球茲卡病毒檢測市場－主要趨勢與促進因素摘要

茲卡病毒的日益普及如何推動對有效檢測解決方案的需求？

茲卡病毒是一種經蚊媒傳播的感染疾病，其傳播已成為一項重大的公共衛生挑戰，尤其是在熱帶和亞熱帶地區。茲卡病毒感染疾病可導致小頭畸形等嚴重的出生缺陷和其他神經系統併發症，其日益流行的現象凸顯了對有效檢測解決方案的需求。拉丁美洲、加勒比地區、東南亞和非洲的一些國家已報告大量感染病例，迫切需要準確、快速的診斷檢測。世界各地的醫療機構和組織都將重點放在早期診斷上，以防止病毒傳播並控制潛在的疫情。因此，茲卡病毒檢測已成為疾病監測計畫的重要組成部分，推動了一系列診斷檢測的需求，包括分子檢測、血清學檢測和照護現場診斷。

哪些技術創新正在提升茲卡病毒檢測能力？

技術進步顯著提高了茲卡病毒檢測能力，使診斷更加準確、快速和可靠。諸如即時聚合酵素鏈鎖反應(RT-PCR) 等分子診斷創新技術因其高靈敏度和特異性，已成為茲卡檢測的新標準。這些檢測可在感染後數天內檢測到病毒 RNA，為及時介入提供關鍵資訊。此外，能夠同時檢測多種黃病毒（例如登革熱和屈公病）的多重檢測方法的開發已在醫療保健提供者中日益普及。快速診斷檢測 (RDT) 和攜帶式核酸增幅檢查(NAAT) 等即時檢測解決方案也因其易於使用、價格實惠且能夠提供對疫情應對至關重要的快速檢測結果，在資源有限的地區也廣受歡迎。

監管部門的核准和資金籌措舉措如何影響茲卡病毒檢測市場？

監管核准和資金籌措在茲卡病毒檢測市場發展中發揮關鍵作用。美國食品藥物管理局(FDA) 和世界衛生組織 (WHO) 等政府機構正積極參與核准和檢驗茲卡病毒新型診斷檢測方法，以確保其符合所需的敏感度和特異性標準。此外，緊急使用授權 (EUA) 的頒發加速了疫情期間創新診斷工具的市場化進程。在資金方面，政府機構、非政府組織 (NGO) 和私人實體不斷增加的投資，為先進茲卡病毒檢測技術的開發和商業化提供了有力支持。此類經濟獎勵正在刺激研發活動，促進利用更穩健、更具可擴展性的檢測解決方案來應對全球健康挑戰。

茲卡病毒檢測市場的成長將受到多種因素的推動

茲卡病毒檢測市場的成長受到多種因素的推動，包括茲卡感染病例的增加、分子照護現場技術的進步，以及醫療基礎設施和疾病監測投資的增加。集體爆發期間對快速準確診斷的需求是主要促進因素，尤其是在茲卡與其他黃病毒共存的流行地區。多重檢測和可攜式核酸檢測 (NAAT) 等技術進步正在提高檢測能力，並擴大偏遠和資源匱乏地區的市場滲透率。此外，監管機構的核准和政府資助計劃正在提高茲卡病毒檢測的可用性和可及性。醫療保健提供者和公眾對早期診斷和預防重要性的認知不斷提高，也促進了市場成長，使茲卡病毒檢測成為全球衛生安全的重要組成部分。

部分

類型（分子、血清學）；最終使用者（研究機構、診斷實驗室、醫院/診所）

受訪公司範例（11家值得關注的公司）

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP15720

Global Zika Virus Testing Market to Reach US$314.5 Million by 2030

The global market for Zika Virus Testing estimated at US$224.5 Million in the year 2024, is expected to reach US$314.5 Million by 2030, growing at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of the analysis period. Growth in the Serological Testing segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$58.7 Million While China is Forecast to Grow at 9.9% CAGR

The Zika Virus Testing market in the U.S. is estimated at US$58.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$75.5 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Zika Virus Testing Market - Key Trends & Drivers Summarized

How Is the Rising Prevalence of Zika Virus Driving the Need for Effective Testing Solutions?

The outbreak of the Zika virus, a mosquito-borne disease, has emerged as a significant public health challenge, particularly in tropical and subtropical regions. The increasing prevalence of Zika virus infections, which can lead to severe birth defects such as microcephaly and other neurological complications, has underscored the need for effective testing solutions. Countries in Latin America, the Caribbean, Southeast Asia, and parts of Africa have reported numerous cases, driving urgent demand for accurate and rapid diagnostic tests. Healthcare authorities and organizations worldwide are emphasizing early diagnosis to prevent the spread of the virus and manage potential outbreaks. Consequently, Zika virus testing has become a critical component of disease surveillance programs, boosting the demand for a variety of diagnostic tests, including molecular assays, serological tests, and point-of-care diagnostics.

What Technological Innovations Are Enhancing Zika Virus Testing Capabilities?

Technological advancements are significantly enhancing the capabilities of Zika virus testing, enabling more accurate, rapid, and reliable diagnosis. Innovations in molecular diagnostics, such as real-time polymerase chain reaction (RT-PCR) tests, have set a new standard for Zika detection due to their high sensitivity and specificity. These tests can detect the viral RNA within days of infection, providing crucial information for timely intervention. Additionally, the development of multiplex assays that can simultaneously test for multiple flaviviruses, such as dengue and chikungunya, is gaining traction among healthcare providers. Point-of-care testing (POCT) solutions, such as rapid diagnostic tests (RDTs) and portable nucleic acid amplification tests (NAATs), are also becoming popular in resource-limited settings due to their ease of use, affordability, and ability to deliver quick results, which are essential for outbreak control.

How Are Regulatory Approvals and Funding Initiatives Influencing the Zika Virus Testing Market?

Regulatory approvals and funding initiatives play a crucial role in shaping the Zika virus testing market. Government agencies, such as the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO), have been actively involved in approving and validating new diagnostic tests for Zika virus, ensuring they meet the necessary sensitivity and specificity criteria. Additionally, the availability of emergency use authorizations (EUAs) has accelerated the market entry of innovative diagnostic tools during outbreaks. On the funding side, increased investment from government bodies, non-governmental organizations (NGOs), and private entities has significantly supported the development and commercialization of advanced Zika virus testing technologies. These financial incentives are driving research and development activities, promoting the availability of more robust and scalable testing solutions to address global health concerns.

The Growth in the Zika Virus Testing Market Is Driven by Several Factors

The growth in the Zika virus testing market is driven by several factors, including the increasing prevalence of Zika infections, advancements in molecular and point-of-care diagnostic technologies, and rising investments in healthcare infrastructure and disease surveillance. The need for rapid and accurate diagnosis during outbreaks is a significant driver, particularly in endemic regions where Zika co-circulates with other flaviviruses. Technological advancements, such as multiplex assays and portable NAATs, are enhancing testing capabilities and expanding the market's reach to remote and resource-limited areas. Additionally, regulatory approvals and government funding initiatives are boosting the availability and accessibility of Zika virus tests. The growing awareness among healthcare providers and the general public about the importance of early diagnosis and prevention is also contributing to market growth, making Zika virus testing a vital component of global health security.

SCOPE OF STUDY:

The report analyzes the Zika Virus Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Molecular Testing, Serological Testing); End-Use (Research Institutes, Diagnostic Laboratories, Hospitals & Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 11 Featured) -

  • Biocan Diagnostics
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Quest Diagnostics, Inc.
  • SD Biosensor, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Zika Virus Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising incidence of Zika virus infections drives demand for advanced testing solutions
    • Growing government initiatives and public health programs boost market growth
    • Technological advancements in diagnostic testing kits enhance market opportunities
    • Increasing adoption of point-of-care testing kits to improve accessibility
    • Development of multiplex assays for simultaneous detection fuels market demand
    • Expansion of laboratory infrastructure in emerging markets spurs market growth
    • Growing awareness among populations about Zika virus testing enhances market potential
    • Strategic collaborations between research institutions and diagnostic companies propel innovation
    • Increasing focus on developing rapid and cost-effective diagnostic solutions drives market
    • Growing investments in research and development for novel testing methods support market expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Zika Virus Testing Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Zika Virus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Molecular Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Molecular Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Serological Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Serological Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • JAPAN
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • CHINA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • EUROPE
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Zika Virus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • FRANCE
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • GERMANY
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Zika Virus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • INDIA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Zika Virus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Zika Virus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Zika Virus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • AFRICA
    • Zika Virus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Zika Virus Testing by Type - Molecular Testing and Serological Testing - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Zika Virus Testing by Type - Molecular Testing and Serological Testing Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Zika Virus Testing by Type - Percentage Breakdown of Value Sales for Molecular Testing and Serological Testing for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Zika Virus Testing by End-Use - Research Institutes, Diagnostic Laboratories and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Zika Virus Testing by End-Use - Percentage Breakdown of Value Sales for Research Institutes, Diagnostic Laboratories and Hospitals & Clinics for the Years 2015, 2025 & 2030

IV. COMPETITION